Recurrent escherichia coli bloodstream infections: Epidemiology and risk factors

Medicine

Volumn 88, Issue 2, 2009, Pages 77-82

  Sanz Garcĩa, Marta ^a   Ferñndez Cruz, Ana ^a   Rodŕ̃guez Cŕ̃, Marta ^a   Cercenado, Emilia ^a   Marin, Mercedes ^a   Mú̃oz, Patricia ^a   Bouza, Emilio ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PALINDROMIC DNA; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BILE DUCT OBSTRUCTION; BLOODSTREAM INFECTION; CHRONIC LIVER DISEASE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT DISEASE; REINFECTION; RELAPSE; RISK FACTOR; SEX RATIO; URINARY TRACT OBSTRUCTION; BACTEREMIA; BLOOD DISEASE; CASE CONTROL STUDY; DRUG UTILIZATION; ESCHERICHIA COLI INFECTION; IMMUNE DEFICIENCY; MICROBIOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; SEX DIFFERENCE; SPAIN; TEACHING HOSPITAL;

AGED; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; BACTEREMIA; CASE-CONTROL STUDIES; DRUG UTILIZATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HEMATOLOGIC NEOPLASMS; HOSPITALS, TEACHING; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECURRENCE; RISK FACTORS; SEX FACTORS; SPAIN;

EID: 63249108545     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/MD.0b013e31819dd0cf     Document Type: Article

References (32)

1. Baran J Jr, Riederer KM, Ramanathan J, Khatib R. Recurrent vancomycin-resistant Enterococcus bacteremia: prevalence, predisposing factors, and strain relatedness. Clin Infect Dis. 2001; 32:1381-1383.
2. Bergman U, Christenson I, Jansson B, Wiholm BE. Auditing hospital drug utilisation by means of defined daily doses per bed-day. A methodological study. Eur J Clin Pharmacol. 1980;17:183-187.
3. Bone RC. The sepsis syndrome. Definition and general approach to management. Clin Chest Med. 1996;17:175-181.
4. Bouza E, Burillo A, Munoz P. Catheter-related infections: diagnosis and intravascular treatment. J Chemother. 2001;13:224-233.
5. Brauner A, Kaijser B, Kuhn I. Recurrent Escherichia coli bacteraemia-clinical characteristics and bacterial properties. J Infect. 1994;28:49-57.
6. Capdevila JA, Almirante B, Pahissa A, Planes AM, Ribera E, Martinez-Vazquez JM. Incidence and risk factors of recurrent episodes of bacteremia in adults. Arch Intern Med. 1994;154:411-415.
7. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245-1251.
8. Cisneros-Herreros JM, Sanchez-Gonzalez M, Prados-Blanco MT, Llanos-Rodriguez C, Vigil-Martin E, Soto-Espinosa de los Monteros B, Pachon-Diaza J. [Blood cultures in the emergency department]. Enferm Infecc Microbiol Clin. 2005;23:135-139.
9. Cotton DJ, Gill VJ, Marshall DJ, Gress J, Thaler M, Pizzo PA. Clinical features and therapeutic interventions in 17 cases of Bacillus bacteremia in an immunosuppressed patient population. J Clin Microbiol. 1987; 25:672-674.
10. Elting LS, Rubenstein EB, Rolston KV, Bodey GP. Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis. 1997;25:247-259.
11. Font B, Lliminana C, Fontanals D, Pineda V, Segura F. Eleven-year study of recurrent pneumococcal bacteremia. Eur J Clin Microbiol Infect Dis. 2001;20:636-638.
12. Fowler VG Jr, Kong LK, Corey GR, Gottlieb GS, McClelland RS, Sexton DJ, Gesty-Palmer D, Harrell LJ. Recurrent Staphylococcus aureus bacteremia: pulsed-field gel electrophoresis findings in 29 patients. J Infect Dis. 1999;179:1157-1161.
13. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988; 16:128-140.
14. Hedrick TL, Evans HL, Smith RL, McElearney ST, Schulman AS, Chong TW, Pruett TL, Sawyer RG. Can we define the ideal duration of antibiotic therapy? Surg Infect (Larchmt). 2006;7:419-432.
15. Hsu RB, Chen RJ, Chu SH. Risk factors for recurrent bacteremia in adult patients with nontyphoid salmonellosis. Am J Med Sci. 2004; 328:315-318.
16. Javaloyas M, Garcia-Somoza D, Gudiol F. [Bacteremia due to Escherichia coli: epidemiological analysis and sensitivity to antibiotics in a county hospital]. Med Clin (Barc). 2003;120:125-127.
17. Javaloyas M, Garcia-Somoza D, Gudiol F. Epidemiology and prognosis of bacteremia: a 10-y study in a community hospital. Scand J Infect Dis. 2002;34:436-441.
18. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546-1554.
19. Maslow JN, Mulligan ME, Arbeit RD. Recurrent Escherichia coli bacteremia. J Clin Microbiol. 1994;32:710-714.
20. McCabe WR JG. Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med. 1962;110:847-855.
21. Methodology. WHO Collaborating Centre for Drug Statistics Methodology. 2006. Available at: http://www.whocc.no/atcddd.
22. Munoz P, Blanco JR, Rodriguez-Creixems M, Garcia E, Delcan JL, Bouza E. Bloodstream infections after invasive nonsurgical cardiologic procedures. Arch Intern Med. 2001;161:2110-2115.
23. Niskanen M, Kari A, Nikki P, Iisalo E, Kaukinen L, Rauhala V, Saarela E, Halinen M. Acute physiology and chronic health evaluation (APACHE II) and Glasgow coma scores as predictors of outcome from intensive care after cardiac arrest. Crit Care Med. 1991;19:1465-1473.
24. Olesen B, Kolmos HJ, Orskov F, Orskov I. A comparative study of nosocomial and community-acquired strains of Escherichia coli causing bacteraemia in a Danish university hospital. J Hosp Infect. 1995;31: 295-304.
25. Olesen B, Kolmos HJ, Orskov F, Orskov I. Escherichia coli bacteraemia in patients with and without haematological malignancies: a study of strain characters and recurrent episodes. J Infect. 1998;36:93-100.
26. Performance Standards for Antimicrobial Susceptibility Testing: 16th Informational Supplement. CLSI/NCCLS document. Vol 26 (No 3). Wayne, PA: Clinical and Laboratory Standards Institute; 2006.
27. Rodriguez C, Munoz P, Rodriguez-Creixems M, Yanez JF, Palomo J, Bouza E. Bloodstream infections among heart transplant recipients. Transplantation. 2006;81:384-391.
28. Rodriguez-Creixems M, Munoz P, Miranda E, Pelaez T, Alonso R, Bouza E. Recurrent pneumococcal bacteremia. A warning of immunodeficiency. Arch Intern Med. 1996;156:1429-1434.
29. Siegman-Igra Y, Fourer B, Orni-Wasserlauf R, Golan Y, Noy A, Schwartz D, Giladi M. Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. Clin Infect Dis. 2002;34:1431-1439.
30. Turett GS, Blum S, Telzak EE. Recurrent pneumococcal bacteremia: risk factors and outcomes. Arch Intern Med. 2001;161:2141-2144.
31. Vila J, Marcos MA, Jimenez de Anta MT. A comparative study of different PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus-A. baumannii complex. J Med Microbiol. 1996;44:482-489.
32. Wendt C, Messer SA, Hollis RJ, Pfaller MA, Wenzel RP, Herwaldt LA. Recurrent gram-negative bacteremia: incidence and clinical patterns. Clin Infect Dis. 1999;28:611-617.